BACKGROUND: Despite being essential to medication adherence, redemption of initial prescriptions (ie, primary adherence) has been investigated only sparsely. OBJECTIVES: The objectives were to determine the frequency and risk factors for primary nonadherence among outpatients with dermatologic conditions. METHODS: Every 15th day during 2006, all patients receiving a prescription for an initial treatment with a previously untried medication were studied. Redemptions were traced in an electronic register after 4 weeks. Exclusions were a result of identical treatments within the last 6 months or hospitalizations within 4 weeks. RESULTS: In all, 30.7% of the 322 eligible patients did not collect their medication. Patients with psoriasis were least adherent with nearly 50% of the prescriptions being unredeemed. LIMITATIONS: Only initial prescriptions for previously untried medications issued to hospital outpatients were studied. CONCLUSIONS: For the clinician, primary nonadherence is an essential differential diagnosis when a given therapy fails.
BACKGROUND: Despite being essential to medication adherence, redemption of initial prescriptions (ie, primary adherence) has been investigated only sparsely. OBJECTIVES: The objectives were to determine the frequency and risk factors for primary nonadherence among outpatients with dermatologic conditions. METHODS: Every 15th day during 2006, all patients receiving a prescription for an initial treatment with a previously untried medication were studied. Redemptions were traced in an electronic register after 4 weeks. Exclusions were a result of identical treatments within the last 6 months or hospitalizations within 4 weeks. RESULTS: In all, 30.7% of the 322 eligible patients did not collect their medication. Patients with psoriasis were least adherent with nearly 50% of the prescriptions being unredeemed. LIMITATIONS: Only initial prescriptions for previously untried medications issued to hospital outpatients were studied. CONCLUSIONS: For the clinician, primary nonadherence is an essential differential diagnosis when a given therapy fails.
Authors: Rebecca Haberman; Lourdes M Perez-Chada; Joseph F Merola; Jose Scher; Alexis Ogdie; Soumya M Reddy Journal: Curr Rheumatol Rep Date: 2018-10-26 Impact factor: 4.592
Authors: U Mrowietz; K Kragballe; K Reich; P Spuls; C E M Griffiths; A Nast; J Franke; C Antoniou; P Arenberger; F Balieva; M Bylaite; O Correia; E Daudén; P Gisondi; L Iversen; L Kemény; M Lahfa; T Nijsten; T Rantanen; A Reich; T Rosenbach; S Segaert; C Smith; T Talme; B Volc-Platzer; N Yawalkar Journal: Arch Dermatol Res Date: 2010-09-21 Impact factor: 3.017
Authors: Bettina Habib; David Buckeridge; Melissa Bustillo; Santiago Nicolas Marquez; Manish Thakur; Thai Tran; Daniala L Weir; Robyn Tamblyn Journal: JAMIA Open Date: 2021-07-31